Clinical trial
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients…
NCT00005823 · Leukemia Research Fund, Other · Completed
Key facts
| NCT number | NCT00005823 |
|---|---|
| Title | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
| Official title | A Randomized Trial for Patients With Acute Myeloid Leukemia or High Risk Myelodysplatic Syndrome Aged 60 or Over |
| Lead sponsor | Leukemia Research Fund, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Drug |
| Interventions | cytarabine, daunorubicin hydrochloride, etoposide, hydroxyurea, idarubicin, mitoxantrone hydrochloride, thioguanine, tretinoin, valspodar |
| Enrollment | 2,000 |
| Start date | Dec 1, 1998 |
| Completion | Dec 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: